摩根大通增持信达生物约49.78万股 每股作价约82.28港元

Group 1 - Morgan Stanley increased its stake in Innovent Biologics (01801) by acquiring 497,823 shares at a price of HKD 82.2756 per share, totaling approximately HKD 40.9587 million [2] - Following the acquisition, Morgan Stanley's total shareholding in Innovent Biologics reached approximately 87,249,700 shares, representing a 5.02% ownership stake [2]